Senti Biosciences
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $0 | $333 | $333 | $255 |
Gross Profit | -1,467 | -1,461 | -1,141 | -25,436 |
EBITDA | -11,889 | -14,840 | -16,953 | 3,528 |
EBIT | -13,356 | -16,301 | -18,427 | 1,713 |
Net Income | -11,203 | -12,111 | -18,716 | -14,923 |
Net Change In Cash | 0 | 333 | 333 | 255 |
Free Cash Flow | -8,345 | -11,697 | -7,041 | -17,237 |
Cash | 15,860 | 23,723 | 35,926 | 39,430 |
Basic Shares | 4,572 | 4,570 | 44,658 | 4,447 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $2,561 | $4,286 | $2,291 | $394 |
Gross Profit | -2,683 | 4,286 | -719 | -15,562 |
EBITDA | -61,521 | -66,709 | -37,414 | -22,471 |
EBIT | -66,765 | -70,629 | -40,424 | -24,456 |
Net Income | -71,058 | -45,791 | -55,319 | -19,862 |
Net Change In Cash | 2,561 | 4,286 | 2,291 | 394 |
Cost of Revenue | 1,696 | |||
Free Cash Flow | -64,433 | -76,270 | -40,178 | -25,334 |
Cash | 35,926 | 57,621 | 56,034 | 30,537 |
Basic Shares | 4,437 | 2,611 | 4,365 | 4,365 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$2.45 |
2024-03-31 | -$0.26 |
2023-12-31 | -$0.41 |
2023-09-30 | $0.24 |
